
Letter to the Editor Re: Impact of Cost-Benefit Analysis on the Selection of Therapeutic Drugs for Patients with Overactive Bladder
Xiuyan Tan, Ying Wang, Shuzhen Cai, Chunquan Song
Letter to the Editor Re: Impact of Cost-Benefit Analysis on the Selection of Therapeutic Drugs for Patients with Overactive Bladder
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |